US2021228508A1PendingUtilityA1
Compositions and methods thereof
Est. expiryAug 26, 2036(~10.1 yrs left)· nominal 20-yr term from priority
A61P 25/00A61K 31/485A61K 31/225A61B 5/4848A61P 25/28A61P 9/00A61K 9/50A61K 31/138A61K 47/585A61P 27/02A61K 31/4535A61K 31/215A61K 45/06A61K 2300/00A61K 31/55A61B 5/398
55
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Compounds of Formula Ior enantiomers thereof, metabolites thereof, derivatives thereof, deuterated derivatives thereof, prodrugs thereof, pharmaceutically acceptable salts thereof, N-oxides thereof, or a combination thereof, processes and intermediates for preparation thereof, compositions thereof, and uses thereof, are provided.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A compound having of Formula I:
wherein,
R 1 , R 2 , and R 3 are C 1-10 alkyl, C 3-10 cycloalkyl, C 5-10 aryl, or C 5-10 heteroaryl;
X is a bond, or C 1-10 alkyl, or —CO—C 1-10 alkyl;
R 4 is NH—R 5 , S—R 5 , O—R 5 , —CO—R 5 , or —CO—O—R 5 wherein R 5 is an acyl radical;
wherein the compound is selected from the group consisting of:
or an enantiomer thereof, metabolite thereof, deuterated derivative thereof, halogenated derivative thereof, prodrug thereof, pharmaceutically acceptable salt thereof, N-oxide thereof, or a combination thereof.
2 . A method of use of a composition comprising a compound of claim 1 for a therapeutic and/or prophylactic treatment for a disease or disorder, comprising administering a therapeutically effective amount of the composition to a subject in need thereof.Join the waitlist — get patent alerts
Track US2021228508A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.